Transaction · 0001193125-26-438662

Umberger Traci S

Umberger Traci S, SR, reported a transaction classified as exercise at KESTRA MEDICAL TECHNOLOGIES, LTD. involving 30000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 411000.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MSR
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Disclosed value$0Shares × reported price
Shares traded30.0k$0.00 per share
Holdings after411kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

KMTS price since this filing

Daily closing prices, with the filing date and available return windows
KMTS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -11.3%1w ago -7.6%1d ago -3.9%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001193125-26-438662
Options
Transaction date
Oct 27, 2026
Filed Oct 29, 2026, 10:44 PM · 2d delay
Shares
30,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
411,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026.

  2. F2

    The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $30.0000 to $30.4202. Upon request, the reporting person will provide to the Issuer…

  3. F3

    Includes 365,919 fully vested options as of the filing date, with the remaining 45,081 options vesting in equal monthly installments through March 6, 2027.

Original filing · 0001193125-26-438662
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

KMTS